A Divalent Recombinant Immunotoxin Formed by a Disulfide Bond between the Extension Peptide Chains

Molecules and Cells

Volumn 12, Issue 3, 2001, Pages 398-402

  Park, Ji Hae ^a   Kwon, Hye Won ^a   Chung, Hee Kyoung ^a   Kim, Ik Hwan ^a   Ahn, Kwangseog ^a   Choi, Eui Ju ^a   Pastan, Ira ^b   Choe, MuHyeon ^a  

^a Korea University   (South Korea)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

B3(Fab) ext PE38 2; Antibody Refolding; B3 Antibody; Cytotoxicity; Divalent Immunotoxin; Pseudomonas Exotoxin A

Indexed keywords

BACTERIAL PROTEIN; HYBRID PROTEIN; IMMUNOTOXIN; MONOCLONAL ANTIBODY; PSEUDOMONAS EXOPROTEIN A PROTEIN, PSEUDOMONAS AERUGINOSA;

ARTICLE; CELL CULTURE; CYTOTOXICITY TEST; GENETICS; IMMUNOLOGY; METABOLISM;

ANTIBODIES, MONOCLONAL; BACTERIAL PROTEINS; CYTOTOXICITY TESTS, IMMUNOLOGIC; IMMUNOTOXINS; RECOMBINANT FUSION PROTEINS; TUMOR CELLS, CULTURED;

EID: 0035981227     PISSN: 10168478     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Allured, V. S., Collier, R. J., Carroll, S. F., and McKay, D. B. (1986) Structure of exotoxin A of Pseudomonas aeruginosa at 3.0 Angstrom. Proc. Natl. Acad. Sci. USA 83, 1320-1324.
2. Baluna, R., Coleman, E., Jones, C., Ghetie, V., and Vitetta, E. S. (2000) The effect of a monoclonal antibody coupled to ricin A chain-derived peptides on endothelial cells in vitro: insights into toxin-mediated vascular damage. Exp. Cell. Res. 258, 417-424.
3. Bera, T. K. and Pastan, I. (1998) Comparison of recombinant IT against Lewis Y Ag expressing tumor cells: influence of affinity, size, and stability. Bioconjug. Chem. 9, 736.
4. Bera, T. K., Viner, J., Brinkmann, E., and Pastan, I. (1999) Pharmacokinetics and antitumor activity of a bivalent disulfide- stabilized Fv immunotoxin with improved antigen binding to erbB2. Cancer Res. 59, 4018-4022.
5. Brinkmann, U., Pai, L. H., FitzGerald, D. J., Willingham, M., and Pastan, I. (1991) B3(Fv)-PE38KDEL, a single-chain immunotoxin that causes complete regression of a human carcinoma in mice. Proc. Natl. Acad. Sci. USA 88, 8616-8620.
6. Brinkmann, U., Buchner, J., and Pastan, I. (1992) Independent domain folding of Pseudomonas exotoxin and single-chain immunotoxins: influence of interdomain connections. Proc. Natl. Acad. Sci. USA 89, 3075-3079.
7. Brinkmann, U., Di Carlo, A., Vasmatzis, G., Kurochkina, N., Beers, R., Lee, B., and Pastan, I. (1997) Stabilization of a recombinant Fv fragment by base-loop interconnection and V(H)-V(L) permutation. J. Mol. Biol. 268, 107-117.
8. Buchner, J., Brinkmann, U., and Pastan, I. (1992a) Renaturation of a single-chain immunotoxin facilitated by chaperones and protein disulfide isomerase. Bio/Technology 10, 682-685.
9. Buchner, J., Pastan, I., and Brinkmann, U. (1992b) A method for increasing the yield of properly folded recombinant fusion proteins: single-chain immunotoxins from renaturation of bacterial inclusion bodies. Anal. Biochem. 205, 263-270.
10. Chae, J.-S., Choi, J.-K., Lim, H.-T., and Cha, S.-H. (2001) Generation of a murine single chain Fv (scFv) antibody specific for cucumber mosaic virus (CMV) using a phage display library. Mol. Cells 11, 7-12.
11. Chaudhary, V. K., Queen, C., Junghans, R. P., Waldmann, T. A., FitzGerald, D. J., and Pastan, I. (1989) A recombinant immunotoxin consisting of two antibody variable domains fused to Pseudomonas exotoxin. Nature 339, 394-397.
12. Choe, M., Webber, K. O., and Pastan, I. (1994) B3(Fab)-PE38M: a recombinant immunotoxin in which a mutant form of Pseudomonas exotoxin is fused to the Fab fragment of monoclonal antibody B3. Cancer Res. 54, 3460-3467.
13. Deonarain, M. P. and Epenetos, A. A. (1998) Design, characterization and anti-tumor cytotoxicity of a panel of recombinant, mammalian ribonuclease-based immunotoxins. Br. J. Cancer 77, 537-546.
14. Freund, C., Ross, A., Pluckthun, A., and Holak, T. A. (1994) Structural and dynamic properties of the Fv fragment and the single-chain Fv fragment of an antibody in solution investigated by heteronuclear three-dimensional NMR spectroscopy. Biochemistry 33, 3296-3303.
15. Hudson, P. J. and Kortt, A. A. (1999) High avidity scFv multimers; diabodies and triabodies. J. Immunol. Methods 231, 177-189.
16. Kim, S.-H., Song, S.-H., Kim, Y.-J., and Park, S.-Y. (2001) Expression and characterization of a recombinant Fab fragment derived from an anti-human alpha-fetoprotein monoclonal antibody. Mol. Cells 11, 158-163.
17. Kreitman, R. J., Wang, Q. C., FitzGerald, D. J., and Pastan, I. (1999) Complete regression of human B-cell lymphoma xenografts in mice treated with recombinant anti-CD22 immunotoxin RFB4(dsFv)-PE38 at doses tolerated by cynomolgus monkeys. Int. J. Cancer 81, 148-155.
18. Pai, L. H., Batra, J. K., FitzGerald, D. J., Willingham, M. C., and Pastan, I. (1991) Anti-tumor activities of immunotoxins made of monoclonal antibody B3 and various forms of Pseudomonas exotoxin [published erratum appears in Proc. Natl. Acad. Sci. USA 88, 5066 (1991)]. Proc. Natl. Acad. Sci. USA 88, 3358-3362.
19. Pastan, I. and FitzGerald, D. (1991) Recombinant toxins for cancer treatment. Science 254, 1173-1177.
20. Reiter, Y., Brinkmann, U., Jung, S. H., Lee, B., Kasprzyk, P. G., King, C. R., and Pastan, I. (1994a) Improved binding and antitumor activity of a recombinant anti-erbB2 immunotoxin by disulfide stabilization of the Fv fragment. J. Biol. Chem. 269, 18327-18331.
21. Reiter, Y., Kreitman, R. J., Brinkmann, U., and Pastan, I. (1994b) Cytotoxic and antitumor activity of a recombinant immunotoxin composed of disulfide-stabilized anti-Tac Fv fragment and truncated Pseudomonas exotoxin. Int. J. Cancer 58, 142-149.
22. Reiter, Y., Wright, A. F., Tonge, D. W., and Pastan, I. (1996) Recombinant single-chain and disulfide-stabilized Fv-immunotoxins that cause complete regression of a human colon cancer xenograft in nude mice. Int. J. Cancer 67, 113-123.
23. Roscoe, D. M., Pai, L. H., and Pastan, I. (1997) Identification of epitopes on a mutant form of Pseudomonas exotoxin using serum from humans treated with Pseudomonas exotoxin containing immunotoxins. Eur. J. Immunol. 27, 1459-1468.
24. Scherf, U., Benhar, I., Webber, K. O., Pastan, I., and Brinkmann, U. (1996) Cytotoxic and antitumor activity of a recombinant tumor necrosis factor- B1(Fv) fusion protein on LeY antigen-expressing human cancer cells. Clin. Cancer Res. 2, 1523-1531.
25. Schmiedl, A., Breitling, F., and Dubel, S. (2000) Expression of a bispecific dsFv-dsFv' antibody fragment in Escherichia coli. Protein Eng. 13, 725-734.
26. Studier, F. W. and Moffatt, B. A. (1986) Use of bacteriophage T7 polymerase to direct selective expression of cloned gene. J. Mol. Biol. 189, 113-130.